iBio, Inc. (IBIO)
iBio, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
iBio, Inc. (IBIO) is a Biotechnology company based in US with a market capitalization of $22.6M. Free cash flow was negative at -$15.3M. This page tracks IBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 16 employees · IPO Aug 19, 2008
Valuation
Valuation & price
$1.47as of May 17, 2026· -52.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.52
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$22.6M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$15.3M
Free cash flow (USD)
-$5.1M
Net debt
Net cash position
174.1%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 12, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 17, 2026Filing
Annual Meeting Scheduled
- 8-K eventJul 1, 2026Filing
Preclinical Data Announcement
- 8-K eventMay 12, 2026Filing
Clinical Trial Initiation
- Quarterly reportMay 12, 2026Filing
10-Q Filed
- 8-K eventMay 8, 2026Filing
Director Appointment
- 8-K eventApr 17, 2026Filing
Warrant Expiration Update
- 8-K eventApr 8, 2026Filing
Clinical Trial Initiation
Questions
Frequently asked questions
What is iBio, Inc.'s market cap?
iBio, Inc. (IBIO) has a market capitalization of $22.6M.
What is IBIO's P/E ratio?
A meaningful P/E ratio is not available for IBIO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is IBIO's price-to-book (P/B) ratio?
IBIO trades at 1.52 times book value per share.
Are insiders buying IBIO stock?
SEC Form 4 filings show no open-market insider buys at iBio, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.